Log in
Login
Password
Remember
Lost password
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Nasdaq  >  Qiagen NV    QGEN   NL0000240000

QIAGEN NV (QGEN)

Delayed Quote. Delayed  - 02/08 01:33:43 pm
20.29 USD   -3.61%
02/03 QIAGEN NV : Investigator human identity testing products meet new IS..
02/02 QIAGEN NV : New agreements underscore QIAGEN’s leadership in b..
02/02 QIAGEN NV : Reports Results for Fourth Quarter and Full-Year 2015
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Income Statement Evolution
Annual Income Statement Data
Actuals in M $ Estimates in M $
Fiscal Period December 201320142015201620172018
Sales1 3061 3451 2811 3331 4191 517
Operating income (EBITDA)404394-431466502
Operating profit (EBIT)318313315313344380
Pre-Tax Profit (EBT)37,3-----
Net income69,1117-170202239
P/E ratio82,148,9-32,127,121,4
EPS ( $ )0,290,48-0,650,780,98
Dividend per Share ( $ )-----0,30
Yield-----1,43%
Reference price ( $ )23.8123.4627.6521.0521.0521.05
Announcement Date01/29/2014
06:00am
01/29/2015
03:06pm
02/02/2016
11:46pm
---
Finances - Leverage
Actuals in M $ Estimates in M $
Fiscal Period December 201320142015201620172018
Debt465595-363172217
Finance------
Operating income (EBITDA)404394-431466502
Leverage
(Debt/EBITDA)
1,15x1,51x-0,84x0,37x0,43x
Capital Expenditure84,586,6-101107109
Book Value Per Share (BVPS)11,6 $11,4 $-11,8 $12,5 $12,3 $
Cash Flow per Share1,07 $1,19 $-1,56 $1,69 $1,83 $
Announcement Date01/29/2014
06:00am
01/29/2015
03:06pm
02/02/2016
11:46pm
---
Balance Sheet Analysis
Assessed data source :
© 2016 Thomson Reuters
Advertisement
Financial Ratios

Size 2016e 2017e
Capitalization 5 046 M$ -
Entreprise Value (EV) 5 409 M$ 5 218 M$
Valuation 2016e 2017e
P/E ratio (Price / EPS) 32,1x 27,1x
Capitalization / Revenue 3,78x 3,55x
EV / Revenue 4,06x 3,68x
EV / EBITDA 12,6x 11,2x
Yield (DPS / Price) - -
Price to book (Price / BVPS) 1,79x 1,69x
Profitability 2016e 2017e
Operating Margin (EBIT / Sales) 23,4% 24,2%
operating Leverage (Delta EBIT / Delta Sales) - 1,56x
Net Margin (Net Profit / Revenue) 12,8% 14,2%
ROA (Net Profit / Asset) 5,61% 6,39%
ROE (Net Profit / Equities) 8,64% 9,26%
Rate of Dividend - -
Balance Sheet Analysis 2016e 2017e
CAPEX / Sales   7,58% 7,51%
Cash Flow / Sales 27,3% 27,7%
Capital Intensity (Assets / Sales) 2,27x 2,23x
Financial Leverage (Net Debt / EBITDA) 0,84x 0,37x
Price Earning Ratio Help 
The blue ligne is the average P/E ratio (without estimates)
EPS & Dividend